Research ArticleNeuropharmacology
Studies of the Biogenic Amine Transporters 15. Identification of Novel Allosteric Dopamine Transporter Ligands with Nanomolar Potency
Richard B. Rothman, Subramaniam Ananthan, John S. Partilla, Surendra K. Saini, Omar Moukha-Chafiq, Vibha Pathak and Michael H. Baumann
Journal of Pharmacology and Experimental Therapeutics June 2015, 353 (3) 529-538; DOI: https://doi.org/10.1124/jpet.114.222299
Richard B. Rothman
Medicinal Chemistry Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland (R.B.R., J.S.P., M.H.B.); and Department of Chemistry, Drug Discovery Division, Southern Research Institute, Birmingham, Alabama (S.A., S.K.S., O.M.-C., V.P.)
Subramaniam Ananthan
Medicinal Chemistry Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland (R.B.R., J.S.P., M.H.B.); and Department of Chemistry, Drug Discovery Division, Southern Research Institute, Birmingham, Alabama (S.A., S.K.S., O.M.-C., V.P.)
John S. Partilla
Medicinal Chemistry Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland (R.B.R., J.S.P., M.H.B.); and Department of Chemistry, Drug Discovery Division, Southern Research Institute, Birmingham, Alabama (S.A., S.K.S., O.M.-C., V.P.)
Surendra K. Saini
Medicinal Chemistry Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland (R.B.R., J.S.P., M.H.B.); and Department of Chemistry, Drug Discovery Division, Southern Research Institute, Birmingham, Alabama (S.A., S.K.S., O.M.-C., V.P.)
Omar Moukha-Chafiq
Medicinal Chemistry Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland (R.B.R., J.S.P., M.H.B.); and Department of Chemistry, Drug Discovery Division, Southern Research Institute, Birmingham, Alabama (S.A., S.K.S., O.M.-C., V.P.)
Vibha Pathak
Medicinal Chemistry Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland (R.B.R., J.S.P., M.H.B.); and Department of Chemistry, Drug Discovery Division, Southern Research Institute, Birmingham, Alabama (S.A., S.K.S., O.M.-C., V.P.)
Michael H. Baumann
Medicinal Chemistry Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland (R.B.R., J.S.P., M.H.B.); and Department of Chemistry, Drug Discovery Division, Southern Research Institute, Birmingham, Alabama (S.A., S.K.S., O.M.-C., V.P.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleNeuropharmacology
DAT Allosteric Modulators
Richard B. Rothman, Subramaniam Ananthan, John S. Partilla, Surendra K. Saini, Omar Moukha-Chafiq, Vibha Pathak and Michael H. Baumann
Journal of Pharmacology and Experimental Therapeutics June 1, 2015, 353 (3) 529-538; DOI: https://doi.org/10.1124/jpet.114.222299
Research ArticleNeuropharmacology
DAT Allosteric Modulators
Richard B. Rothman, Subramaniam Ananthan, John S. Partilla, Surendra K. Saini, Omar Moukha-Chafiq, Vibha Pathak and Michael H. Baumann
Journal of Pharmacology and Experimental Therapeutics June 1, 2015, 353 (3) 529-538; DOI: https://doi.org/10.1124/jpet.114.222299
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement